Aldeyra Therapeutics, Inc.
For the period ended Jun 10, 2025. Filed Apr 27, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 10, 2025 · Filed Apr 27, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.)
Filed by the Registrant ☒
Filed by a party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|---|
| ☒ | Definitive Proxy Statement |
|---|
| ☐ | Definitive Additional Materials |
|---|
| ☐ | Soliciting Material under Rule 14a-12 |
|---|
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| ☒ | No fee required. |
|---|
| ☐ | Fee paid previously with preliminary materials. |
|---|
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|---|
April 27, 2026
You are cordially invited to attend the 2026 Annual Meeting of Stockholders of Aldeyra Therapeutics, Inc. that will be held on Tuesday, June 9, 2026 at 9:00 a.m. local time, at the offices of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, One Marina Park Drive, Suite 900, Boston, Massachusetts 02210.
Details regarding admission to the Annual Meeting and the business to be conducted are described in the accompanying proxy materials. Also included is a copy of our annual report on Form 10-K for the year ended December 31, 2025. We encourage you to read this information carefully. Your vote is important. Whether or not you plan to attend the Annual Meeting, we hope you will vote as soon as possible. You may vote over the Internet, by telephone, or by mailing a proxy card, if you have requested one. Voting over the Internet, by telephone or by written proxy will ensure your representation at the Annual Meeting regardless of whether or not you attend in person. Please review the instructions on the Notice of Internet Availability of Proxy Materials you have received in the mail regarding each of the voting options.
Thank you for your ongoing support of Aldeyra.
Very truly yours,
Todd C. Brady, M.D., Ph.D.
Chief Executive Officer, President, and Director
131 HARTWELL AVENUE, SUITE 320
LEXINGTON, MASSACHUSETTS 02421
NOTICE OF ANNUAL MEETING
FOR 2026 ANNUAL MEETING OF STOCKHOLDERS
| Time and Date: | Tuesday, June 9, 2026 at 9:00 a.m. local time. |
|---|---|
| Place: | Offices of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, One Marina Park Drive, Suite 900, Boston Massachusetts 02210. |
| Items of Business: | Proposal 1: To elect the one director named in the proxy statement accompanying this notice to serve as a Class III director until the annual meeting held in 2029, or until his successor is duly elected and qualified. Proposal 2: To ratify the appointment of BDO USA, P.C. as Aldeyra Therapeutics, Inc.’s independent registered public accounting firm for the year ending December 31, 2026. Proposal 3: To approve, on a non-binding, advisory basis, the compensation of our named executive officers as described in this proxy statement. To transact such other business as may properly come before the annual meeting or any adjournment thereof. These items of business are more fully described in the proxy statement accompanying this notice. |
| Adjournments and Postponements: | Any action on the items of business described above may be considered at the annual meeting at the time and on the date specified above or at any time and date to which the annual meeting may be properly adjourned or postponed. |
| Record Date: | You are entitled to vote if you were a stockholder of record as of the close of business on April 13, 2026. |
| Voting: | Your vote is very important. Whether or not you plan to attend the annual meeting, we encourage you to read the proxy statement and vote on the Internet, by telephone or by mailing a proxy card, if you have requested one, as soon as possible. For specific instructions on how to vote your shares, please refer to the section entitled “Questions and Answers about Procedural Matters.” |
If you have any questions regarding this information or the proxy materials, please visit our website at www.aldeyra.com or contact Laura Nichols, our Associate Director of Investor Relations & Business Operations, at (781)257-3060.
All stockholders of record are cordially invited to attend the Annual Meeting.
By order of the Board of Directors,
Todd C. Brady, M.D., Ph.D.
Chief Executive Officer, President and Director
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to Be Held on June 9, 2026: The proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 are available free of charge at www.proxyvote.com.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.